Biotehnološko podjetje je dobilo dovoljenje, da poskuša oživiti mrtve

    692

    Biotehnološko podjetje Bioquark je dobilo dovoljenje etične komisije, da lahko začne klinično študijo na 20 pacientih, v kateri bodo preučevali, ali lahko pri klinično mrtvih zaradi poškodbe možganov ponovno oživijo del centralnega živčnega sistema.

    Scientists will use a combination of therapies, which include injecting the brain with stem cells and a cocktail of peptides, as well as deploying lasers and nerve stimulation techniques which have been shown to bring patients out of comas.
    The trial participants will have been certified dead and only kept alive through life support. They will be monitored for several months using brain imaging equipment to look for signs of regeneration, particularly in the upper spinal cord – the lowest region of the brain stem which controls independent breathing and heartbeat.
    The team believes that the brain stem cells may be able to erase their history and re-start life again, based on their surrounding tissue – a process seen in the animal kingdom in creatures like salamanders who can regrow entire limbs.
    Dr Ira Pastor, the CEO of Bioquark Inc. said: “This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime.
    … Commenting on the trial, Dr Dean Burnett, a neuroscientist at the Cardiff University’s Centre for Medical Education said: “While there have been numerous demonstrations in recent years that the human brain and nervous system may not be as fixed and irreparable as is typically assumed, the idea that brain death could be easily reversed seems very far-fetched, given our current abilities and understanding of neuroscience.
    “Saving individual parts might be helpful but it’s a long way from resurrecting a whole working brain, in a functional, undamaged state.”
    (Vir: Dead could be brought ‘back to life’ in groundbreaking project – The Telegraph)

    Opis klinične študije najdete tule: Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury – Full Text View – ClinicalTrials.gov